Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Chamberlain R, Canes D, Brown K, Saltz L, Jarnagin W, Fong Y, et al. Hepatic neuroendocrine metastases: does intervention alter outcome? J Am Coll Surg 2000; 190: 432-45. http://dx.doi.org/10.1016/S1072-7515(00)00222-2ChamberlainRCanesDBrownKSaltzLJarnaginWFongYHepatic neuroendocrine metastases: does intervention alter outcome?J Am Coll Surg2000190432432http://dx.doi.org/10.1016/S1072-7515(00)00222-210.1016/S1072-7515(00)00222-2Search in Google Scholar
Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumors. Ann Oncol 2001; 12 (Suppl 2): S95-9.TomassettiPMiglioriMLalliSCampanaDTomassettiVCorinaldesiREpidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumorsAnn Oncol200112 (Suppl 2)S95910.1093/annonc/12.suppl_2.S95Search in Google Scholar
Madoff D, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 2006; 17: 1235-49; quiz 1250. 10.1097/01.RVI.0000232177.57950.71MadoffDGuptaSAhrarKMurthyRYaoJCUpdate on the management of neuroendocrine hepatic metastasesJ Vasc Interv Radiol200617123549quiz 125010.1097/01.RVI.0000232177.57950.7110.1097/01.RVI.0000232177.57950.7116923972Search in Google Scholar
Mayo S, De Jong M, Bloomston M, Pulitano C, Clary B, Reddy S, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metastases: a multicenter international analysis. Ann Surg Oncol 2011; 18: 3657-65. 10.1245/s10434-010-1343-2MayoSDe JongMBloomstonMPulitanoCClaryBReddySSurgery versus intra-arterial therapy for neuroendocrine liver metastases: a multicenter international analysisAnn Surg Oncol2011183657365710.1245/s10434-010-1343-210.1245/s10434-011-1832-y21681380Search in Google Scholar
Arrese D, McNally ME, Chokshi R, Feria-Arias E, Schmidt C, Klemanski D, et al. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma. Ann Surg Oncol 2013; 20: 1114-20. 10.1245/s10434-012-2786-4ArreseDMcNallyMEChokshiRFeria-AriasESchmidtCKlemanskiDExtrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinomaAnn Surg Oncol2013201114111410.1245/s10434-012-2786-410.1245/s10434-012-2786-423456380Search in Google Scholar
Ruutiainen A, Soulen M, Tuite C, Clark T, Mondschein J, Stavropoulos S, et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 2007; 18: 847-55. 10.1016/j. jvir.2007.04.018RuutiainenASoulenMTuiteCClarkTMondscheinJStavropoulosSChemoembolization and bland embolization of neuroendocrine tumor metastases to the liverJ Vasc Interv Radiol20071884784710.1016/j. jvir.2007.04.01810.1016/j.jvir.2007.04.01817609443Search in Google Scholar
Ho A, Picus J, Darcy MD, Tan B, Gould JE, Pilgram TK, et al. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol 2007; 188: 1201-7. 10.2214/AJR.06.0933HoAPicusJDarcyMDTanBGouldJEPilgramTKLong-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumorsAJR Am J Roentgenol20071881201120110.2214/AJR.06.093310.2214/AJR.06.093317449759Search in Google Scholar
Hur S, Chung J, Kim H, Oh D, Lee S, Bang Y, et al. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases. J Vasc Interv Radiol 2013; 24: 947-56. 10.1016/j.jvir.2013.02.030HurSChungJKimHOhDLeeSBangYSurvival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastasesJ Vasc Interv Radiol20132494794710.1016/j.jvir.2013.02.03010.1016/j.jvir.2013.02.03023602421Search in Google Scholar
Devcic Z, Rosenberg J, Braat A, Techasith T, Banerjee A, Sze D, et al. The efficacy of hepatic 90Y resin radioembolization for metastastic neuroendocrine tumors: a meta-analysis. J Nuc Med 2014; 55: 1404-10. 10.2967/ jnumed.113.135855DevcicZRosenbergJBraatATechasithTBanerjeeASzeDThe efficacy of hepatic 90Y resin radioembolization for metastastic neuroendocrine tumors: a meta-analysisJ Nuc Med2014551404140410.2967/jnumed.113.13585510.2967/jnumed.113.13585525012459Search in Google Scholar
Memon K, Lewandowski R, Mulcahy M, Riaz A, Ryu R, Sato K, et al. Radioembolization for neuroendocrine liver metastases: safety, imaging and long-term outcomes. Int J Radiat Oncol Biol Phys 2012; 83: 887-94. 10.1016/j.ijrobp.2011.07.041MemonKLewandowskiRMulcahyMRiazARyuRSatoKRadioembolization for neuroendocrine liver metastases: safety, imaging and long-term outcomesInt J Radiat Oncol Biol Phys20128388788710.1016/j.ijrobp.2011.07.04110.1016/j.ijrobp.2011.07.041329770322137020Search in Google Scholar
de Baere T, Deschamps F, Tselikas L, Ducreux M, Planchard D, Pearson E, et al. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs. Eur J Endocrinol 2015; 172: R151-66. 10.1530/EJE-14-0630de BaereTDeschampsFTselikasLDucreuxMPlanchardDPearsonEGEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETsEur J Endocrinol2015172R1516610.1530/EJE-14-063010.1530/EJE-14-063025385817Search in Google Scholar
Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al; PRECISION V Investigators. Prospective randomized study of doxorubicineluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION study. Cardiovasc Intervent Radiol 2010; 33: 41-45. 10.1007/s00270-009-9711-7LammerJMalagariKVoglTPilleulFDenysAWatkinsonAPRECISION V Investigators. Prospective randomized study of doxorubicineluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION studyCardiovasc Intervent Radiol201033414110.1007/s00270-009-9711-710.1007/s00270-009-9711-7281679419908093Search in Google Scholar
Dekervel J, van Malenstein H, Vandecaveye V, Nevens F, van Pelt J, Heye S, et al. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. J Vasc Interv Radiol 2014; 25: 248-55. 10.1016/j.jvir.2013.10.017DekervelJvan MalensteinHVandecaveyeVNevensFvan PeltJHeyeSTranscatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-upJ Vasc Interv Radiol20142524824810.1016/j.jvir.2013.10.01710.1016/j.jvir.2013.10.01724295569Search in Google Scholar
Huppert P, Wenzel T, Wietholtz H. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population. Cardiovasc Intervent Radiol 2014; 37: 154-64. 10.1007/s00270-013-0632-0HuppertPWenzelTWietholtzHTranscatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient populationCardiovasc Intervent Radiol20143715415410.1007/s00270-013-0632-010.1007/s00270-013-0632-023670568Search in Google Scholar
Aliberti C, Fiorentini G, Muzzio PC, Pomerri F, Tilli M, Dallara S, et al. Transarterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study. Anticancer Res 2011; 31: 4581-7.AlibertiCFiorentiniGMuzzioPCPomerriFTilliMDallaraSTransarterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical studyAnticancer Res20113145814581Search in Google Scholar
Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G, et al. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 2007; 21: 1085-91.FiorentiniGAlibertiCTurrisiGDel ConteARossiSBeneaGIntraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical studyIn Vivo20072110851085Search in Google Scholar
van Malenstein H, Maleux G, Vandecaveye V, Heye S, Laleman W, van Pelt J, et al. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma. Onkologie 2011; 34: 368-76. 10.1159/000329602van MalensteinHMaleuxGVandecaveyeVHeyeSLalemanWvan PeltJA randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinomaOnkologie20113436836810.1159/00032960210.1159/00032960221734423Search in Google Scholar
Varela M, Real M, Burrel M, Forner A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007; 46: 474-81. 10.1016/j.jhep.2006.10.020VarelaMRealMBurrelMFornerASalaMBrunetMChemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokineticsJ Hepatol20074647447410.1016/j.jhep.2006.10.02010.1016/j.jhep.2006.10.02017239480Search in Google Scholar
Vogl T, Lammer J, Lencioni R, Malagari K, Watkinson A, Pilleul F, et al. Liver, gastrointestinal and cardiac toxicity in intermediate hepatocellular carcinoma with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial. AJR Am J Roentgenol 2011; 197: W562-70. 10.2214/AJR.10.4379VoglTLammerJLencioniRMalagariKWatkinsonAPilleulFLiver, gastrointestinal and cardiac toxicity in intermediate hepatocellular carcinoma with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trialAJR Am J Roentgenol2011197W5627010.2214/AJR.10.437910.2214/AJR.10.437921940527Search in Google Scholar
Bhagat N, Reyes D, Lin M, Kamel I, Pawlik T, Frangakis C, et al. Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury. Cardiovasc Intervent Radiol 2013: 36: 449-59. 10.1016/j.jvir.2012.08.028BhagatNReyesDLinMKamelIPawlikTFrangakisCPhase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injuryCardiovasc Intervent Radiol20133644944910.1016/j.jvir.2012.08.02810.1007/s00270-012-0424-y359648522722717Search in Google Scholar
Guiu B, Descamps F, Aho S, Munck F, Dromain C, Boige V, et al. Liver/biliary injuries following chemoembolization of endocrine tumours and hepatocellular carcinoma: lipiodol versus drug-eluting beads. J Hepatol 2012: 56: 609-617. 10.1016/j.jhep.2011.09.012GuiuBDescampsFAhoSMunckFDromainCBoigeVLiver/biliary injuries following chemoembolization of endocrine tumours and hepatocellular carcinoma: lipiodol versus drug-eluting beadsJ Hepatol20125660960910.1016/j.jhep.2011.09.01210.1016/j.jhep.2011.09.01222027582Search in Google Scholar
Joskin J, de Baere T, Auperin A, Tselikas L, Guiu B, Farouil G, et al. Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor. Cardiovasc Intervent Radiol 2015; 38: 372-380. 10.1016/j.jhep.2011.09.012JoskinJde BaereTAuperinATselikasLGuiuBFarouilGPredisposing factors of liver necrosis after transcatheter arterial chem-oembolization in liver metastases from neuroendocrine tumorCardiovasc Intervent Radiol20153837237210.1016/j.jhep.2011.09.01210.1007/s00270-014-0914-124873919Search in Google Scholar
De Baere T, Deschamps F, Teriitheau C, Rao P, Conengrapht K, Schlumberger M, et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicineluting beads: preliminary results. J Vasc Interv Radiol 2008; 19: 855-61. 10.1016/j.jvir.2008.01.030De BaereTDeschampsFTeriitheauCRaoPConengraphtKSchlumbergerMTransarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicineluting beads: preliminary resultsJ Vasc Interv Radiol20081985585510.1016/j.jvir.2008.01.03010.1016/j.jvir.2008.01.03018503899Search in Google Scholar
Sakamoto I, Iwanaga S, Nagaoki K, Matsuoka Y, Ashizawa K, Uetani M, et al. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol 2003; 181: 79-87. 10.2214/ajr.181.1.1810079SakamotoIIwanagaSNagaokiKMatsuokaYAshizawaKUetaniMIntrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolizationAJR Am J Roentgenol2003181797910.2214/ajr.181.1.181007910.2214/ajr.181.1.181007912818833Search in Google Scholar
Gaur S, Friese J, Sadow C, Ayyagari R, Binkert C, Schenker M, et al. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver. Cardiovasc Intervent Radiol 2011; 34: 566-72. 10.1007/s00270-011-0122-1GaurSFrieseJSadowCAyyagariRBinkertCSchenkerMepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liverCardiovasc Intervent Radiol20113456656610.1007/s00270-011-0122-110.1007/s00270-011-0122-121431978Search in Google Scholar
Loewe C, Schindl M, Cejna M, Niederle B, Lammer J, Thurnher S. Permanent transarterial embolization of neuroendocrine metastases of th eliver using cyanoacrylate and lipiodol: assessment of mid-and long-term results. AJR Am J Roentgenol 2003; 180: 1379-84. 10.2214/ajr.180.5.1801379LoeweCSchindlMCejnaMNiederleBLammerJThurnherSPermanent transarterial embolization of neuroendocrine metastases of th eliver using cyanoacrylate and lipiodol: assessment of mid-and long-term resultsAJR Am J Roentgenol20031801379137910.2214/ajr.180.5.180137910.2214/ajr.180.5.180137912704055Search in Google Scholar
Bilbao J, de Luis E, García de Jalón JA, de Martino A, Lozano MD, de la Cuesta AM, et al. Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation. J Vasc Interv Radiol 2008; 19: 1625-38. 10.1016/j.jvir.2008.07.014BilbaoJde LuisEGarcía de JalónJAde MartinoALozanoMDde la CuestaAMComparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluationJ Vasc Interv Radiol2008191625162510.1016/j.jvir.2008.07.01410.1016/j.jvir.2008.07.01418823795Search in Google Scholar
De Luis E, Bilbao JI, de Ciércoles JA, Martínez-Cuesta A, de Martino Rodríguez A, Lozano MD. In vivo evaluation of a new embolic spherical particle (HepaSphere) in a kidney animal model. Cardiovasc Intervent Radiol 2008; 31: 367-76. 10.1007/s00270-007-9240-1De LuisEBilbaoJIde CiércolesJAMartínez-CuestaAde Martino RodríguezALozanoMDIn vivo evaluation of a new embolic spherical particle (HepaSphere) in a kidney animal modelCardiovasc Intervent Radiol20083136736710.1007/s00270-007-9240-110.1007/s00270-007-9240-118167024Search in Google Scholar
